Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic model may improve treatment and diagnosis for certain inherited skin diseases.

Higher IL-37 levels are linked to more severe alopecia areata, but the gene variation doesn't affect disease risk.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Researchers found a gene mutation responsible for a rare hair loss condition.

DM and AA may share a common cause.

Genetic analysis is crucial for diagnosing and managing cerebral arteriopathy.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

DKK4 can be used to improve wool quality in Zhexi Angora rabbits.

Genetic testing can diagnose hair loss linked to DSG4 gene variants.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

AB+ blood group is more common in alopecia areata patients.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Alopecia areata involves immune response and gene changes affecting hair loss.

Truncated hHb1 keratin may play a role in breast cancer cell transformation.

A specific gene mutation causes vitamin D-resistant rickets and hair loss.

Screening for the NUDT15 gene variant can prevent severe side effects from thiopurine drugs in East-Asian people.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Cells that move well may improve hair loss treatments by entering hair follicles.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.